Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE – COALITION VIII randomised clinical trial-Reference-Cited by-同舟云学术

Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE – COALITION VIII randomised clinical trial

Published:2023-06 Issue: Volume:60 Page:102004
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Avezum Álvaro^ORCID,Oliveira Junior Haliton Alves^ORCID,Neves Precil Diego M.M.,Alves Lucas Bassolli O.^ORCID,Cavalcanti Alexandre B.,Rosa Regis G.,Veiga Viviane C.,Azevedo Luciano C.P.,Zimmermann Sérgio Luiz,Silvestre Odilson Marcos,Seabra Prudente Raphael Cruz,Morales Kormann Adrian Paulo,Moreira Frederico Rafael,Boszczowski Icaro,de Brito Sobrinho Edgar,da Silva e Souza André,Seligman Renato^ORCID,de Souza Paolino Bruno,Razuk Alvaro^ORCID,Diogenes de Magalhaes Feitosa Audes,Monteiro Belmonte Pedro Luiz,Freitas das Neves Gonçalves Priscila,Hernandes Mauro Esteves,Fagundes Ariovaldo Leal^ORCID,Sarmet Esteves José Maria,Tognon Alexandre Pereira,Eikelboom John^ORCID,Berwanger Otávio,Lopes Renato D.,Oliveira Gustavo B.F.

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis;Nopp;Res Pract Thromb Haemost,2020

2. Venous and arterial thrombosis in ambulatory and discharged COVID-19 patients: a systematic review and meta-analysis;Mansory;TH Open,2022

3. Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis;Zuin;J Thromb Thrombolysis,2023

4. Hematological findings and complications of COVID-19;Terpos;Am J Hematol,2020

5. Severe COVID-19 is a microvascular disease;Lowenstein;Circulation,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial;Research and Practice in Thrombosis and Haemostasis;2024-07

2. 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19;Journal of Thrombosis and Haemostasis;2024-06

3. Prophylactic-dose direct oral anticoagulants for non-hospitalised people with COVID-19: A meta-analysis of randomised controlled trials;Journal of Global Health;2024-04-26

4. Thromboprophylaxis for outpatients with COVID-19: a Systematic Review and Meta-analysis;Journal of Thrombosis and Thrombolysis;2024-04-26

5. Effectiveness and safety of rivaroxaban for anticoagulation therapy in COVID-19;Saudi Medical Journal;2024-04